BRCA1 and ovarian neoplasm: We found that both BRCA1 and BRCA2 ovarian tumors without locus-specific LOH treated with adjuvant platinum based chemotherapy have lower overall survival than tumors with locus-specific LOH, at rates similar to sporadic tumors.